The estimated Net Worth of Capital Fund, Lp Acuta is at least $7.07 Milion dollars as of 4 January 2018. Capital Acuta owns over 54,463 units of IRIDEX stock worth over $7,070,786 and over the last 7 years Capital sold IRIX stock worth over $0.
Capital has made over 6 trades of the IRIDEX stock since 2017, according to the Form 4 filled with the SEC. Most recently Capital bought 54,463 units of IRIX stock worth $55,008 on 4 January 2018.
The largest trade Capital's ever made was buying 336,681 units of IRIDEX stock on 4 January 2018 worth over $390,550. On average, Capital trades about 153,384 units every 31 days since 2017. As of 4 January 2018 Capital still owns at least 3,483,146 units of IRIDEX stock.
You can see the complete history of Capital Acuta stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 1301 Shoreway Rd #350, Belmont, CA 94002, USA.
Over the last 21 years, insiders at IRIDEX have traded over $1,952,092 worth of IRIDEX stock and bought 1,330,571 units worth $7,196,100 . The most active insiders traders include Joshua Makower, James B Hawkins oraz Capital Fund, Lp Acuta. On average, IRIDEX executives and independent directors trade stock every 32 days with the average trade being worth of $18,723. The most recent stock trade was executed by Nandini Devi on 20 May 2022, trading 2,000 units of IRIX stock currently worth $6,200.
iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.
IRIDEX executives and other stock owners filed with the SEC include: